Guidelines for the management of basal cell carcinoma. British Association of Dermatologists.
These guidelines on the management of basal cell carcinoma have been prepared for dermatologists on behalf of the British Association of Dermatologists. They present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation.
Telfer
N R
NR
Departments of Dermatology, University of Manchester, Manchester, UK.
Colver
G B
GB
Bowers
P W
PW
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000175:diagnosis / Q000601:surgery* / Q000628:therapy; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D010166:Palliative Care; D010789:Phototherapy; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000175:diagnosis / Q000601:surgery* / Q000628:therapy
D000964:Antimetabolites, Antineoplastic; D007370:Interferon Type I; D011994:Recombinant Proteins; D005472:Fluorouracil